EligibleTrials

Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS

Recruiting · NCT07255911 · Interventional (participants receive a specific treatment) · Lead sponsor: Mst.Sumyara Khatun

View the official record on ClinicalTrials.gov →
PCOS

Interventions studied

Cabergoline 0.5 mgLetrozole 0.5mg

What this trial is about

Does combined Cabergoline and letrozole increase ovulation rate What medical problems do participants have when taking drug Cabergoline and Letrozole ? Researchers will compare drug combination of Cabergoline and letrozole to letrozole alone to see combined cabergoline and letrozole works better as ovulation induction. Participants will: experimental group will receive Cabergoline and Letrozole comparator group will receive letrozole alone TVS Monitoring will be done for 3 cycle for ovarian response

Who can take part

Age range
18 Years to 35 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.